$0.6200
Last update: Dec 31, 7:00 PM
Comments
Loading...
Ampio Pharmaceuticals Analyst Ratings and Price Targets | OTC:AMPE | Benzinga
Ampio Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Ampio Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Ampio Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Ampio Pharmaceuticals (AMPE) stock?
There is no price target for Ampio Pharmaceuticals
What is the most recent analyst rating for Ampio Pharmaceuticals (AMPE)?
There is no analyst for Ampio Pharmaceuticals
When was the last upgrade for Ampio Pharmaceuticals (AMPE)?
There is no last upgrade for Ampio Pharmaceuticals
When was the last downgrade for Ampio Pharmaceuticals (AMPE)?
There is no last downgrade for Ampio Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Ampio Pharmaceuticals (AMPE)?
There is no next analyst rating for Ampio Pharmaceuticals.
Is the Analyst Rating Ampio Pharmaceuticals (AMPE) correct?
There is no next analyst rating for Ampio Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.